Who
Jennifer Michaelson
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Cullinan Therapeutics.
In numbers
- Trades disclosed
- 129
- Buys
- 0
- Sells
- 45
- Bought
- $0
- Sold
- $6.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Jan 2021
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Code M | $17K4,000 at $4.30 | filing |
| 8 Sep 2026filed 10 Sep 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $173K8,000 at $21.57 | filing |
| 8 Sep 2026filed 10 Sep 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Code M | $17K4,000 at $4.30 | filing |
| 8 Sep 2026filed 10 Sep 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $173K8,000 at $21.57 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Code M | $129K30,000 at $4.30 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $608K30,000 at $20.26 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Code M | $129K30,000 at $4.30 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $608K30,000 at $20.26 | filing |
| 6 Jul 2026filed 7 Jul 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Code M | $17K4,000 at $4.30 | filing |
| 6 Jul 2026filed 7 Jul 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $143K8,000 at $17.82 | filing |
| 6 Jul 2026filed 7 Jul 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Code M | $17K4,000 at $4.30 | filing |
| 6 Jul 2026filed 7 Jul 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $143K8,000 at $17.82 | filing |
| 5 May 2026filed 6 May 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Code M | $17K4,000 at $4.30 | filing |
| 5 May 2026filed 6 May 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $114K7,800 at $14.60 | filing |
News
Jennifer Michaelson Sells 8,000 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stockthemarketsdaily.com · 10 Sep 2026
1 headline in the last 90 days name Jennifer Michaelson; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.